Biotech in the Autoimmune/Fibrosis Therapeutics Space
Aeschenvorstadt 36, 4051 Basel, Switzerland
plusbiome AG is a Swiss startup company working at the interface of digital health and the microbiome. We design and market customised probiotics that truly support customers and their well-being,. Customers also profit from accompanying Apps.
Somagenetix is a Spin-off from the Univ of Zurich leveraging scientific, clinical and commercial expertise to solve unmet medical needs through gene therapy. We aim at becoming a leading gene therapy company with first-in-class and best-in-class treatment for phagocyte-related disorders.
Adoram Therapeutics is developing a suite of small molecule allosteric modulators for different indications. Our primary asset in the preclinical stage, is a negative allosteric modulator (NAM) of a clinically validated immuno-oncology target - the adenosine 2A receptor (A2AR).